Diagram of lungs

DCA presenting poster at DDL27 on designing respiratory health devices

Published on: 6th December 2016

DCA are exhibiting at the Drug Delivery to the Lungs Conference (DDL), in Edinburgh, this week and will be presenting a poster on a structured approach for designing respiratory health devices.

Many pharmaceutical companies see equivalence claims as the fastest and most cost effective route to market for new respiratory drug devices. In reality though, the process is often not as simple as first thought. By their very nature, equivalence claims mean adopting existing, often old, technologies and user interfaces. Furthermore, the task of demonstrating equivalence can be protracted and expensive. Thus, in many cases, manufacturers are left accepting sub-optimal devices, with known usability issues. Moreover, opportunities may be missed to explore different products, technologies and services that would improve usability, compliance, patient satisfaction and market share. This paper, and poster discuss an approach that uses tools from the discipline of human factors to explore device requirements from first principles.

The approach is based on the premise that better designs are informed by an explicit understanding of what information is required, where and when, along with an understanding of who needs it, and how it should be presented. These information requirements are explored at the earliest stages of the design process and revisited throughout the design.